Time-course of recovery of 5-HT1A receptors and changes in 5-HT1A receptor mRNA after irreversible inactivation with EEDQ

Akiyoshi, 1993, Paradoxical increase of 5-hydroxytryptamine2 receptors and 5-hydroxytryptamine2 mRNA in cerebellar granule cells after persistant 5-hydroxytrypaamine2 receptor stimulation, Mol. Pharmacol., 43, 349 Angulo, 1991, Regulation by dopaminergic neurotransmission of dopamine D2 mRNA and receptor levels in the striatum and nucleus accumbens of the rat, Mol. Brain Res., 11, 161, 10.1016/0169-328X(91)90117-G Artymyshyn, 1990, The use of 3H standards in 125I autoradiography, J. Neurosci. Methods., 32, 185, 10.1016/0165-0270(90)90139-7 Barker, 1993, 5-Hydroxytryptamine1C receptor density and mRNA levels in choroid plexus epithelial cells after treatment with mianserin and (−)-1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropane, Mol. Pharmacol., 44, 725 Battaglia, 1987, Differential serotonin2 receptor recovery in mature and senescent rat brain after irreversible receptor modification: effect of chronic reserpine treatment, J. Pharmacol. Exp. Ther., 243, 69 Battaglia, 1986, Functional recovery of D1 dopamine receptor-mediated stimulation of rat striatal adenylate cyclase activity following irreversible receptor modification by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ): evidence for spare receptors, Neurosci. Lett., 69, 290, 10.1016/0304-3940(86)90496-9 Belleau, 1969, The mechanism of irreversible adrenergic blockade by N-carbethoxydihydroquinolines. Model studies with typical serine hydrolases, Biochem. Pharmacol., 18, 1039, 10.1016/0006-2952(69)90107-5 Bernard, 1991, Striatal neurons express increased level of dopamine D2 receptor mRNA in response to haloperidol treatment: a quantitative in situ hybridization study, Neuroscience, 45, 117, 10.1016/0306-4522(91)90108-Z Blier, 1990, A role for the serotonin system in the mechanism of action of antidepressant treatments: preclinical evidence, J. Clin. Psychiatry, 51, 14 Bolanos, 1991, Recovery of 5-HT1A receptors after irreversible blockade by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ), 34, 387 Brousseau, 1990, Localization of 5-HT1A receptor mRNA in rat brain, Soc. Neurosci. Abstr., 16, 290.6 Butler, 1993, Chronic electroconvulsive seizures increase the expression of serotonin2 receptor mRNA in rat frontal cortex, J. Neurochem., 61, 1270, 10.1111/j.1471-4159.1993.tb13618.x Chalmers, 1993, Corticosteroids regulate brain hippocampal 5-HT1A receptor mRNA expression, J. Neurosci., 13, 914, 10.1523/JNEUROSCI.13-03-00914.1993 Chang, 1970, Mechanism of cholinergic antagonism by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ), Pharmacol. Res. Commun., 2, 63, 10.1016/S0031-6989(70)80035-2 Daval, 1987, Transient expression of 5-HT1A receptor binding sites in some areas of the rat CNS during postnatal development, Int. J. Dev. Neurosci., 5, 171, 10.1016/0736-5748(87)90027-X Dourish, 1986, 8-OH-DPAT-induced hyperphagia: its neural basis and possible therapeutic relevance, Appetite, 7, 127, 10.1016/S0195-6663(86)80058-7 Eison, 1990, Serotonin: a common neurobiological substrate in anxiety and depression, J. Clin. Psychopharmacol., 10, 26s, 10.1097/00004714-199006001-00006 Frankfurt, 1994, Effect of 5,7-dihydroxytryptamine, ovariectomy and gonadal steroids on serotonin receptor binding in rat brain, Neuroendocrinology, 59, 245, 10.1159/000126665 Frankfurt, 1993, Alterations of serotonin receptor binding in the hypothalamus following acute denervation, Brain Res., 601, 349, 10.1016/0006-8993(93)91735-B Frazer, 1990, 5-HT1A receptors and 5-HT1A-mediated responses: Effects of treatments that modify serotonergic neurotransmission, Ann. NY Acad. Sci., 600, 460, 10.1111/j.1749-6632.1990.tb16902.x Glennon, 1990, Serotonin receptors: clinical implications, Neurosci. Biobehav. Rev., 14, 35, 10.1016/S0149-7634(05)80158-7 Gozlan, 1994, Differential effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on various 5-HT receptor binding sites in the rat brain, Neuropharmacology, 33, 423, 10.1016/0028-3908(94)90072-8 Hadcock, 1989, Agonist-induced destabilization of β-adrenergic receptor mRNA, J. Biol. Chem., 264, 19928, 10.1016/S0021-9258(19)47200-1 Hensler, 1991, A quantitative autoradiographic study of serotonin1A receptor regulation. Effects of 5,7-dihydroxytryptamine and antidepressant treatments, Neuropsychopharmacology, 4, 131 Kopp, 1992, Effect of raclopride on dopamine D2 receptor mRNA expression in rat brain, Neuroscience, 47, 771, 10.1016/0306-4522(92)90028-Z Kung, 1994, A potential 5-HT1A antagonist: p-MPPI, Life Sci., 55, 1459, 10.1016/0024-3205(94)00686-5 Levy, 1992, Endocrine and receptor pharmacology of serotonergic anxiolytics, antipsychotics and antidepressants, Life Sci., 51, 83, 10.1016/0024-3205(92)90001-6 Liao, 1993, Loss of 5-HT1A receptor mRNA in the dentate gyrus of long-term adrenalectomized rats and rapid reversal by dexamethasone, Mol. Brain Res., 19, 328, 10.1016/0169-328X(93)90134-B Lisovoski, 1992, Induction of D2 dopamine receptor mRNA synthesis in a 6-hydroxydopamine parkinsonian rat model, Brain Res. Bull., 28, 697, 10.1016/0361-9230(92)90248-V Lopez, 1993, Corticosteroid regulation of serotonin 1A receptor mRNA and binding in the hippocampus, Neuropsychopharmacology, 9, 845 McGonigle, 1994, In vivo occupancy of D2 and D3 receptors determined with EEDQ, Soc. Neurosci. Abstr., 20, 224.16 Meller, 1985, Inactivation of D1 and D2 dopamine receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo: selective protection by neuroleptics, J. Pharmacol. Exp. Ther., 233, 656 Meller, 1990, Receptor reserve for 5-HT1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists, Mol. Pharmacol., 37, 231 Murphy, 1990, Neuropsychiatric disorders and the multiple human brain serotonin receptor subtypes and subsystems, Neuropsychopharmacology, 3, 457 Pazos, 1985, Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. serotonin-1 receptors, Brain Res., 346, 205, 10.1016/0006-8993(85)90856-X Pinto, 1993, In vivo EEDQ dose-dependently inactivates rat brain 5-HT receptors but not 5-HT uptake sites, NeuroReport, 5, 61, 10.1097/00001756-199310000-00015 Roque, 1991, Upregulation of dopamine D2 receptor mRNA in rat striatum by chronic neuroleptic treatment, Eur. J. Pharmacol., 207, 165, 10.1016/0922-4106(91)90092-V Roth, 1991, Chronic mianserin treatment decreases 5-HT2 receptor binding without altering 5-HT2 receptor mRNA levels, Eur. J. Pharmacol., 207, 169, 10.1016/0922-4106(91)90093-W Tejani-Butt, 1993, Time course of altered thyroid states on 5-HT1A receptors and 5-HT uptake sites in rat brain: an autoradiographic analysis, Neuroendocrinology, 57, 1011, 10.1159/000126465 Traber, 1987, 5-HT1A receptor-related anxiolytics, Trends Pharmacol. Sci., 8, 432, 10.1016/0165-6147(87)90231-8 Tricklebank, 1985, The involvement of the subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioral response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat, Eur. J. Pharmacol., 106, 271, 10.1016/0014-2999(84)90714-3 Verge, 1986, Quantitative autoradiography of multiple 5-HT1 receptor subtypes in the brain of control or 5,7-dihydroxytryptamine-treated rats, J. Neurosci., 6, 3474, 10.1523/JNEUROSCI.06-12-03474.1986 Xu, 1991, Regulation of D1A and D2 dopamine receptor mRNA during ontogenesis, lesion and chronic antagonist treatment, Life Sci., 50, 383, 10.1016/0024-3205(92)90440-Z Xu, 1991, N-(p-Iso-thiocyanatophenethyl)spiperone, a selective and irreversible antagonist of D2 dopamine receptors in brain, J. Pharmacol. Exp. Ther., 257, 608 Yocca, 1992, Lack of apparent receptor reserve at postsynaptic 5-hydroxytryptamine1A receptors negatively coupled to adenylyl cyclase activity in rat hippocampal membranes, Mol. Pharmacol., 41, 1066 Zhuang, 1994, Synthesis and evaluation of 4-(2′-methoxyphenyl)-1-[2′-[N-(2″-pyridinyl)-piodobenzamido]ethyl]piperazine (p-MPPI): A new iodinated 5-HT1A ligand, J. Med. Chem., 37, 1406, 10.1021/jm00036a003